Company Description
Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs.
Significant Investors
Khosla Ventures, First Round Capital, The Longevity Fund, Lachy Groom, BoxGroup, Collab Fund, Bain Capital Ventures, Valor Equity Partners
